PROCEPT BioRobotics (PRCT) Earnings Date, Estimates & Call Transcripts $81.17 +0.39 (+0.48%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PROCEPT BioRobotics Latest Earnings SummaryActual EPS (Oct. 28) -$0.40 Beat By $0.09 Consensus EPS (Oct. 28) -$0.49 PROCEPT BioRobotics released Q3 2024 earnings on October 28, 2024, reporting an EPS of -$0.40, which beat the consensus estimate of -$0.49 by $0.09. Quarterly revenue rose 66.4% year-over-year to $58.40 million, above analysts' expectations of $53.30 million. With a trailing EPS of -$1.95, PROCEPT BioRobotics' earnings are expected to grow next year, from ($1.75) to ($1.28) per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K FilingPowered by Get PROCEPT BioRobotics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PROCEPT BioRobotics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPRCT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PRCT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. PROCEPT BioRobotics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.56-$0.49-$0.53Q2 20242-$0.55-$0.53-$0.54Q3 20242-$0.49-$0.48-$0.49Q4 20242-$0.35-$0.34-$0.35FY 20248-$1.95-$1.84-$1.90Q1 20252-$0.38-$0.33-$0.36Q2 20252-$0.37-$0.30-$0.34Q3 20252-$0.29-$0.27-$0.28Q4 20252-$0.19-$0.17-$0.18FY 20258-$1.23-$1.07-$1.15Q1 20261-$0.19-$0.19-$0.19Q2 20261$0.20$0.20$0.20Q3 20261$0.16$0.16$0.16 PROCEPT BioRobotics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails10/28/2024Q3 2024-$0.49-$0.40+$0.09-$0.40$53.30M$58.40M8/1/2024Q2 2024-$0.52-$0.50+$0.02-$0.50$50.10M$53.35M5/1/2024Q1 2024-$0.55-$0.51+$0.04-$0.51$41.58M$44.50M2/27/2024Q4 2023-$0.44-$0.54 -$0.10-$0.54$41.79M$43.58M11/1/2023Q3 2023-$0.53-$0.51+$0.02-$0.51$33.44M$35.10M7/27/2023Q2 2023-$0.57-$0.56+$0.01-$0.56$30.25M$33.10M Get the Latest News and Ratings for PRCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PROCEPT BioRobotics and its competitors with MarketBeat's FREE daily newsletter. 4/27/2023Q1 2023-$0.59-$0.63 -$0.04-$0.63$24.32M$24.40M2/28/2023Q4 2022-$0.53-$0.56 -$0.03-$0.49$23.70M$23.78M PROCEPT BioRobotics Earnings - Frequently Asked Questions When did PROCEPT BioRobotics announce their last quarterly earnings? PROCEPT BioRobotics (NASDAQ:PRCT) last announced its quarterly earning data on Monday, October 28, 2024. Learn more on PRCT's earnings history. What guidance has PROCEPT BioRobotics issued on next quarter's earnings? PROCEPT BioRobotics issued an update on its FY 2024 earnings guidance on Monday, October, 28th. The company issued revenue guidance of $222.5 million-$223.0 million, compared to the consensus revenue estimate of $217.1 million. Did PROCEPT BioRobotics beat their earnings estimates last quarter? In the previous quarter, PROCEPT BioRobotics (NASDAQ:PRCT) reported ($0.40) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.49) by $0.09. Learn more on analysts' earnings estimate vs. PRCT's actual earnings. How can I listen to PROCEPT BioRobotics's earnings conference call? The conference call for PROCEPT BioRobotics's latest earnings report can be listened to online. Listen to Conference Call How can I read PROCEPT BioRobotics's conference call transcript? The conference call transcript for PROCEPT BioRobotics's latest earnings report can be read online. Read Transcript How can I view PROCEPT BioRobotics's earnings report? PROCEPT BioRobotics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does PROCEPT BioRobotics generate each year? PROCEPT BioRobotics (NASDAQ:PRCT) has a recorded annual revenue of $199.84 million. How much profit does PROCEPT BioRobotics generate each year? PROCEPT BioRobotics (NASDAQ:PRCT) has a recorded net income of -$105.90 million. PRCT has generated -$1.95 earnings per share over the last four quarters. What is PROCEPT BioRobotics's EPS forecast for next year? PROCEPT BioRobotics's earnings are expected to grow from ($1.75) per share to ($1.28) per share in the next year. More Earnings Resources from MarketBeat Related Companies Solventum Earnings Penumbra Earnings Glaukos Earnings Bausch + Lomb Earnings Inspire Medical Systems Earnings Axonics Earnings NovoCure Earnings Envista Earnings Inari Medical Earnings iRhythm Technologies Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover This page (NASDAQ:PRCT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRCT Stock Alerts